Skip to main content
. 2011 Nov 29;7(1):233–240. doi: 10.1007/s12072-011-9320-9

Fig. 2.

Fig. 2

Strength of reactions with antibodies to Flk-1, VEGF A, and CD34 measured by densitometry in morbidly obese and nonobese NAFLD patients